Callable Multi Barrier Reverse Convertible

Symbol: ZMFLTQ
ISIN: CH1336231936
Issuer:
Leonteq Securities
Trade

Chart

    
    

SIX Structured Products trading

SIX Structured Products Bid Ask Notation
Please note that data is only available after start of trading.

Performance

Closing prev. day 67.95
Diff. absolute / % -3.53 -5.03%

Determined prices

Last Price 70.16 Volume 12,000
Time 15:46:48 Date 11/03/2025

More Product Information

Core Data

Name Callable Multi Barrier Reverse Convertible
ISIN CH1336231936
Valor 133623193
Symbol ZMFLTQ
Barrier 511.59 USD
Cap 867.10 USD
Quotation in percent Yes
Coupon p.a. 10.00%
Coupon Premium 8.90%
Coupon Yield 1.10%
Type Barrier Reverse Convertibles
SVSP Code 1230
Barrier reached Yes (Novo Nordisk AS (B) - 12/03/2025)
COSI Product No
Exercise type American
Currency Swiss Franc
First Trading Date 08/04/2024
Date of maturity 08/10/2025
Last trading day 29/09/2025
Settlement Type Path-dependent
IRS 871m Potentially in scope for combined transactions
Currency safeguarded Yes
Pricing Dirty
Issuer Leonteq Securities

Key data

Sideways yield p.a. -

market maker quality Date: 12/03/2025

Average Spread 1.00%
Last Best Bid Price 65.97 %
Last Best Ask Price 66.63 %
Last Best Bid Volume 250,000
Last Best Ask Volume 250,000
Average Buy Volume 250,000
Average Sell Volume 250,000
Average Buy Value 165,452 CHF
Average Sell Value 167,114 CHF
Spreads Availability Ratio 99.46%
Quote Availability 99.46%

Underlyings

Name Pfizer Inc. Eli Lilly & Co. Novo Nordisk AS (B)
ISIN US7170811035 US5324571083 DK0062498333
Price 23.7425 EUR 805.00 CHF 71.11 EUR
Date 14/03/25 07:51 05/03/25 09:06 14/03/25 07:49
Cap 27.75 USD 777.96 USD 867.10 DKK
Distance to Cap -1.955 23.59 -359.5
Distance to Cap in % -7.58% 2.94% -70.82%
Is Cap Level reached No No No
Barrier 16.3725 USD 458.996 USD 511.589 DKK
Distance to Barrier 9.4225 342.554 18.911
Distance to Barrier in % 36.53% 42.74% 3.56%
Is Barrier reached No No Yes

Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.